Bortezomib in multiple myeloma: Treatment and retreatment. A single center experience

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 6, 2008, Pages 753-756

  Warzocha, Krzysztof ^a   Kraj, Maria ^a   Pogłód, Ryszard ^a   Kwaśniak, Beata ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Bortezomib; Multiple myeloma

Indexed keywords

BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; PYRAZINE DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE PAIN; BRAIN EMBOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG WITHDRAWAL; ERYTHEMA; ERYTHEMA MULTIFORME; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HERPES ZOSTER; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOTENSION; ILEUS; INFECTION; INSOMNIA; LIMB PAIN; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NAUSEA; NEUTROPENIA; PARESTHESIA; PERIPHERAL NEUROPATHY; PLASMA CELL LEUKEMIA; PROGRESSION FREE SURVIVAL; RASH; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; DEXAMETHASONE; DOXORUBICIN; FEMALE; HUMANS; LEUKEMIA, PLASMA CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM RECURRENCE, LOCAL; PYRAZINES; TREATMENT OUTCOME;

EID: 61549108887     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Richardson P.G., Barlogie B., Berenson J., et al.: N. Engl. J. Med. 348, 2609 (2003).
2. Richardson P.G., Sonneveld P., Schuster M.W., et al.: N. Engl. J. Med. 352, 2487 (2005).
3. Warzocha K., Kraj M., Pogłód R., Sokołowska U.: Nowotwory Journal of Oncology 57, (2007).
4. Mateos M-V., Hernández J.M., Miguel T., et al.: Haematologica 93, 560 (2008).
5. Ma M.H., Yang H.H., Parker K., et al.: Clin. Cancer Res. 9, 1136 (2003).
6. Hideshima T., Mitsiades C., Akiyama M., et al.: Blood 101, 1530 (2003).
7. Or=owski R.Z., Voorhees P.M., Garcia R.A., et al.: Blood 105, 3058 (2005).
8. Oakervee H.E. Popat R., Curry N., et al: Br. J. Haematol. 129, 755 (2005).
9. Musto P., Barone M., Guariglia R., et al.: Blood 108, (2006) Abstract 3546.
10. Kraj M., Pogłód R., Szpila T., Warzocha K.: Acta Haematol. Pol. 38 Suppl 1, 156 (2007).
11. Durie B.G.M., Harousseau J-L., Miguel J.S., et al.: Leukemia 20, 1467 (2006).
12. Greipp P.R., San Miguel J., Durie B.G.M., et al: J. Clin. Oncol. 23, 3412 (2005).
13. Wolf J.L., Richardson P., Schuster M., et al.: Blood 108 (2006) Abstract 3532.
14. Conner T.M., Doan Q.Ch.D., Le Blanc A.L., et al.: Blood 108 (2006) Abstract 3531.
15. Hrusovsky I., Emmerich B., Engelhardt M., et al.: Blood 118, 798a (2007) Abstract 2720.
16. Bilalis A.G., Papadimitriou K., Pouli A., et al.: Blood 118, 279B (2007) Abstract 4819.
17. Morris T.C.M., Kettle P.J., Drake M., et al.: Blood 118, 800a (2007) Abstract 2724.